F. Carneiro

Venous thromboembolism and prostate cancer: what about genetic markers?

R. Medeiros, Valéria Tavares, S. Abreu, 2021, Pharmacogenomics.

Reviewing Treatment Options for Advanced Renal Cell Carcinoma: Is There Still a Place for Tyrosine Kinase Inhibitor (TKI) Monotherapy?

F. Carneiro, Mário Fontes-Sousa, H. Magalhães, 2022, Advances in Therapy.

Low Golimumab Trough Levels at Week 6 are Associated with Poor Clinical, Endoscopic and Histological Outcomes in Ulcerative Colitis Patients: Pharmacokinetic and Pharmacodynamic Sub-analysis of the Evolution Study.

M. Cravo, P. Lago, F. Magro, 2019, Journal of Crohn's & colitis.

Anxiety and Depression in Patients with Prostate Cancer, at Cancer Diagnosis and after a One-Year Follow-Up

N. Lunet, N. Araújo, Jorge Oliveira, 2022, International journal of environmental research and public health.

YB-1 variant and androgen receptor axis-targeted agents in metastatic castration-resistant prostate cancer patients.

R. Medeiros, S. Coelho, Jani Silva, 2020, Pharmacogenomics.

Prevalence of Cognitive Impairment before Prostate Cancer Treatment

N. Lunet, N. Araújo, L. Ruano, 2022, Cancers.